Bumetanide-induced NKCC1 inhibition attenuates oxygen-glucose deprivation-induced decrease in proliferative activity and cell cycle progression arrest in cultured OPCs via p-38 MAPKs - PubMed (original) (raw)

Bumetanide-induced NKCC1 inhibition attenuates oxygen-glucose deprivation-induced decrease in proliferative activity and cell cycle progression arrest in cultured OPCs via p-38 MAPKs

Peicai Fu et al. Brain Res. 2015.

Abstract

The Na-K-Cl co-transporter 1 (NKCC1; a member of the cation-chloride co-transporter family) mediates the coupled movement of Na(+) and/or K(+) with Cl(-) across the plasma membrane of cells (Haas and Forbush, 2000, Annu. Rev. Physiol., 62, 515-534; Russell, 2000, Physiol. Rev., 80, 211-276). Although it acts as an important regulator of cell volume, secretion, and modulator of cell apoptosis and proliferation (Chen et al., 2005, J. Cereb. Blood Flow Metab., 25, 54-66; Kahle et al., 2008, Nat. Clin. Pract. Neurol., 4, 490-503; Kidokoro et al., 2014, Am. J. Physiol. Ren. Physiol., 306, F1155-F1160; Wang et al., 2011, Cell. Physiol. Biochem., 28, 703-714), NKCC1׳s effects on oligodendrocyte precursor cells (OPCs) have not been characterized. The aim of this study was to investigate whether and to what extent inhibition of NKCC1 alters oxygen glucose deprivation (OGD)-induced cell cycle progression. In the present study, we demonstrated that inhibition of NKCC1 with bumetanide attenuates the decrease in OGD-induced DNA synthesis in cultured OPCs. Western blots showed that NKCC1 inhibition led to an increased expression of cyclin D1, CDK 4, and cyclin E in OGD-treated cells. Furthermore, our results showed bumetanide attenuated the decrease in OGD-induced proliferation and arrest of cell cycle progression via the P-38 MAPK signaling cascade. Thus, NKCC1 plays important roles in the proliferation of OPCs under OGD-induced stress.

Keywords: Cell cycle; Na–K–Cl co-transporter 1 (NKCC1); OPCs; Oxygen/glucose deprivation (OGD).

PubMed Disclaimer

Cited by

NKCC1 Inhibition Attenuates Chronic Cerebral Hypoperfusion-Induced White Matter Lesions by Enhancing Progenitor Cells of Oligodendrocyte Proliferation.
Yu Y, Fu P, Yu Z, Xie M, Wang W, Luo X. Yu Y, et al. J Mol Neurosci. 2018 Mar;64(3):449-458. doi: 10.1007/s12031-018-1043-0. Epub 2018 Mar 3. J Mol Neurosci. 2018. PMID: 29502291
Roles of glial ion transporters in brain diseases.
Song S, Luo L, Sun B, Sun D. Song S, et al. Glia. 2020 Mar;68(3):472-494. doi: 10.1002/glia.23699. Epub 2019 Aug 16. Glia. 2020. PMID: 31418931 Free PMC article. Review.
Elevated NKCC1 transporter expression facilitates early post-traumatic brain injury seizures.
Liang B, Huang JH. Liang B, et al. Neural Regen Res. 2017 Mar;12(3):401-402. doi: 10.4103/1673-5374.202939. Neural Regen Res. 2017. PMID: 28469651 Free PMC article. No abstract available.
NKCC1-Deficiency Results in Abnormal Proliferation of Neural Progenitor Cells of the Lateral Ganglionic Eminence.
Magalhães AC, Rivera C. Magalhães AC, et al. Front Cell Neurosci. 2016 Aug 17;10:200. doi: 10.3389/fncel.2016.00200. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27582690 Free PMC article.
Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1.
Luo WD, Min JW, Huang WX, Wang X, Peng YY, Han S, Yin J, Liu WH, He XH, Peng BW. Luo WD, et al. J Neuroinflammation. 2018 Jun 20;15(1):186. doi: 10.1186/s12974-018-1221-6. J Neuroinflammation. 2018. PMID: 29925377 Free PMC article.

Bumetanide-induced NKCC1 inhibition attenuates oxygen-glucose deprivation-induced decrease in proliferative activity and cell cycle progression arrest in cultured OPCs via p-38 MAPKs - PubMed (original) (raw)